Tag: AstraZeneca
-
AstraZeneca setting up R&D centre in Cambridge, Massachusetts
•
LONDON: AstraZeneca has announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation…
-
AstraZeneca signs multi-billion dollar deal with Ionis Pharmaceuticals
•
LONDON, UK: AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as…
-
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
•
LONDON, UK: AstraZeneca has agreed to transfer its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol)…
-
AstraZeneca to fully acquire Caelum Biosciences
•
LONDON, UK: AstraZeneca‘s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101,…
-
AstraZeneca plans $360 million Irish manufacturing investment
•
LONDON, UK: AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules…
-
AstraZeneca complete acquisition of Alexion Pharmaceuticals
•
LONDON, UK: AstraZeneca today completed the acquisition of Alexion Pharmaceuticals Inc. The closing of the acquisition marks the…
-
AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
•
LONDON, UK: AstraZeneca PLC has appointed Aradhana Sarin as an Executive Director and Chief Financial Officer, conditional upon…
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
•
LONDON: AstraZeneca‘s COVID-19 vaccine, Vaxzevria, formerly AZD1222, has been granted a special approval for emergency use in Japan…
-
AstraZeneca US vaccine trial met primary endpoint
•
LONDON: The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing…
-
AstraZeneca notifies non-executive board changes
•
LONDON: AstraZeneca PLC announced today that Non-Executive Directors Geneviève Berger and Graham Chipchase intend to retire from the…
-
AstraZeneca agrees to divest Viela shareholding for upto $780mn
•
STOCKHOLM: AstraZeneca Plc has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio…
-
COVID-19 Vaccine AstraZeneca authorised for use in the EU
•
LONDON: AstraZeneca‘s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the European Union (EU) for…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.